Comparative characteristics of osmolarity, tear production and state of the corneal epithelium after instillations of the preparations Visomitin and hypromellose

Introduction. Dry eye syndrome (DES) is a multifactorial disease of the ocular surface, characterized by changes in its homeostasis and accompanied by ocular symptoms, the etiology of which is associated with destabilization of the tear film, hyperosmolarity, inflammation, damage to the structures of the ocular surface and neurosensory disorders.

Objective. To study the effect of a drug containing plastoquinonyldecyltriphenylphosphonium bromide (PDTP, SkQ1) on dynamics of osmolarity and reparative properties of the cornea.

Materials and methods. The study included 23 patients (46 eyes) aged 23 to 49 years. All patients presented complaints of dryness, burning sensation, cramps and discomfort in the eyes, increased sensitivity with instillation of drops, periodic blurred vision. Patients underwent standard and special ophthalmic examinations. The patients were divided into two groups comparable in gender and quantitative composition.

Results. Based on the results of the examination at the starting visit, all patients were diagnosed with DES mild or moderate study. After one week of therapy, a significant decrease in subjective complaints was noted patients who received the drug with PDTF. All patients tolerated the drug well. In the group of patients who received a tear replacement therapy with hypromellose, in most patients, while complaints of dryness persist, decreased a feeling of pain in the eyes. A month later, complaints persisted only in patients of this group, but their intensity was known significantly reduced compared to the visit after a week. Against the background of therapy with the drug with PDTP, significant improvement of the Schirmer test, Norn test and corneal staining, as well as with the help of a in vivo confocal microscopy shows a decrease in the number of Langerhans cells.

Conclusion. The results obtained indicate a positive effect of PDTP on the structure of the ocular surface even with its short-term use due to its keratoprotective and anti-inflammatory action. 

1. Craig J.P., Nelson J.D., Azar D.T., Belmonte C., Bron A.J., Сhauhan S.K. et al. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017;15(4):802–812. doi: 10.1016/j.jtos.2017.08.003.

2. Tomlinson A., Madden L.C., Simmons P.A. Effectiveness of dry eye therapy under conditions of environmental stress. Curr Eye Res. 2013;38(2):229–236. doi:10.3109/02713683.2012.757323.

3. Lee J.E., Kim N.M., Yang J.W., Kim S.J., Lee J.S., Lee J.E. A randomised controlled trial comparing a thermal massager with artificial teardrops for the treatment of dry eye. Br J Ophthalmol. 2014;98(1):46–51. doi: 10.1136/ bjophthalmol-2013-303742.

4. Iester M., Orsoni G.J., Gamba G., Taffara M., Mangiafico P., Giuffrida S., Rolando M. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca. Eye (Lond). 2000;14(6):892–898. doi: 10.1038/eye.2000.244.

5. Messmer E.M., Bulgen M., Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol. 2010;45:129–138. doi: 10.1159/000315026.

6. Brzheskiy V.V., Efimova E.L., Vorontsova T.N., Alekseev V.N., Gusarevich O.G., Shaidurova K.N. et al. Results of a Multicenter, Randomized, DoubleMasked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome. Adv Ther. 2015;32(12):1263–1279. doi: 10.1007/s12325-015-0273-6.

7. Tomlinson A., Madden L.C., Simmons P.A. Effectiveness of dry eye therapy under conditions of environmental stress. Curr Eye Res. 2013;38(2):229–236. doi: 10.3109/02713683.2012.757323.

8. Report of the 2007 International Dry Eye WorkShop (DEWS) Glossary. Ocul Surf. 2007;5(2):73–74. doi: 10.1016/s1542-0124(12)70080-0.

9. Emelina V.G., Linnik E.A., Koledintsev M.N., Maychuk N.V. Possibilities for early diagnosis and prognosis of «dry eye» in contact correction. New technologies in the treatment of corneal diseases. In: Takhchidi H.P. (ed.). Fedorov readings – 2004: materials of the All-Russian scientific-practical conference with international participation "New technologies in the treatment of corneal diseases", Moscow, June 25–26, 2004. Moscow: State Institution MNTK "Eye Microsurgery"; 2004. рp. 679–682. (In Russ.)

10. Yeh S., Song X.J., Farley W., Li D.Q., Stern M.E., Pflugfelder S.C. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci. 2003;44(1):124–129. doi: 10.1167/iovs.02-0581.

11. Iaccheri B., Torroni G., Cagini C., Fiore T., Cerquaglia A., Lupidi M. et al. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine. Eye (Lond). 2017;31(5):788–794. doi: 10.1038/eye.2017.3.

12. Steshenko O.N., Mitichkina T.S. The tear fluid qualitative characteristization in patients after lacrimal gland excision. Oftalmologiceskie vedomosti = Ophthalmology Journal. 2013;(6)4:46–50. (In Russ.) doi: 10.17816/OV2013446-50.

13. Gilyazova I.I., Babushkin A.Eh. Tear osmolarity results for different hypotensive glaucoma therapies. Tochka zreniya. Vostok-Zapad = Point of View. East – West. 2014;(2):37–38. (In Russ.) Available at: https://eyepress.ru/article.aspx?15115.

14. Bron A.J., Tiffany J.M., Yokoi N., Gouveia M.S. Using osmolarity to diagnose dry eye: a compartmental hypothesis and reviw of our assumption. Adv Exp Ned Biol. 2002;506(1):1087–1095. doi: 10.1007/978-1-4615-0717-8_153.

15. Tomlinson A., Khanal S., Ramaesh K., Diaper C., McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10):4309–4315. doi: 10.1167/iovs.05-1504.